Technical Data
E2280-30A
Encephalitis, Japan, Nakayama
Description:
Applications:
Suitable for use in ELISA and Immunofluorescence. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Source:
Ascites

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG111C215Purified
SizeStorageShippingSourceHost
100ug-20°CBlue IceMouse
Concentration:
~1mg/ml
Immunogen:
Japanese Encephalitis Virus, Nakayama strain.
Purity:
Purified
Form
Supplied as a liquid in 0.02M PBS, pH7.6, 0.25M sodium chloride, 0.1% sodium azide.
Specificity:
Recognizes epitope E-8 on the E protein of Japanese Encephalitis Virus (Nakayama). Crossreactivity: St. Louis encephalitis (MSI-7), West Nile (EG 101) and Murray Valley encephalitis. Does not crossreact with Yellow Fever or Dengue Virus.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Arunachalam, N., et al., (2004), “Japanese encephalitis in Kerala, south India: can Mansonia (Diptera: Culicidae) play a supplemental role in Transmission?”, J. Med. Entomol., 41: 456-461. 2. Rajendran, R., et al., (2003), “Longitudinal studies in South Indian villages on Japanese encephalitis virus infection in mosquitoes and seroconversion in goats”, Trop. Med. Int. Health, 8: 174-181. 3. Roehrig, J.T., et al., (2001), “Antibody phophylaxis and therapy for flavivirus encephalitis infections”, In West Nile Virus: Detection, Surveillance and Controls, Eds., D.J. White and D.L. Morse, New York , Acad. Sci., New York, NY., 286-297. 4. Pike, A., et al., (2001), “The appearance of a second genotype of Japanese Encephalitis Virus in the Australasian region”, Am. J. Trop. Med. Hyg., 65: 747-753.